GSK Cuts Price Of Cervarix Vaccine By 30% In Singapore

SHANGHAI - GlaxoSmithKline has announced the company recently reduced the price of its cervical cancer vaccine Cervarix by 30 percent in Singapore

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip